154 related articles for article (PubMed ID: 7811027)
21. Comparative in vitro antimicrobial susceptibilities of a special panel of 74 Bacteroides fragilis group isolates in Wilkins-Chalgren agar with and without sheep blood.
Gill CJ; Shungu DL; Ponticas S
Antimicrob Agents Chemother; 1989 Mar; 33(3):394-5. PubMed ID: 2729933
[TBL] [Abstract][Full Text] [Related]
22. Synergy between spiramycin and metronidazole in the treatment of polymicrobial infections.
Brook I
J Antimicrob Chemother; 1988 Jul; 22 Suppl B():77-85. PubMed ID: 3141350
[TBL] [Abstract][Full Text] [Related]
23. In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides.
Aldridge KE; Sanders CV; Marier RL
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):47S-53S. PubMed ID: 6086218
[TBL] [Abstract][Full Text] [Related]
24. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
25. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
Bajaksouzian S; Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Sep; 40(9):1973-6. PubMed ID: 8878565
[TBL] [Abstract][Full Text] [Related]
26. [Sensitivity of anaerobes to 8 antibiotics].
Sedallian A
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):645-7. PubMed ID: 3534760
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the in vitro action and interaction of cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides spp.
Aldridge KE
Diagn Microbiol Infect Dis; 1989; 12(1):45-50. PubMed ID: 2714072
[TBL] [Abstract][Full Text] [Related]
28. Comparison of agar dilution, microdilution, and disk elution methods for measuring the synergy of cefotaxime and its metabolite against anaerobes.
Smith JA; Henry D; Ngui-Yen J; Castell A; Coderre S
J Clin Microbiol; 1986 Jun; 23(6):1104-8. PubMed ID: 2872231
[TBL] [Abstract][Full Text] [Related]
29. [In vitro activity of a combination of amoxicillin-clavulanic acid on anaerobic bacteria].
Sedallian A; Roudon T
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):678-81. PubMed ID: 3054746
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of the two principal oxidative metabolites of metronidazole against Bacteroides fragilis and related species.
Haller I
Antimicrob Agents Chemother; 1982 Jul; 22(1):165-6. PubMed ID: 7125628
[TBL] [Abstract][Full Text] [Related]
31. Emerging metronidazole resistance in Bacteroides spp. and its association with the nim gene: a study from North India.
Sethi S; Shukla R; Bala K; Gautam V; Angrup A; Ray P
J Glob Antimicrob Resist; 2019 Mar; 16():210-214. PubMed ID: 30342928
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin.
Martin SJ; Pendland SL; Chen C; Schreckenberger PC; Danziger LH
Diagn Microbiol Infect Dis; 1997 Nov; 29(3):167-71. PubMed ID: 9401809
[TBL] [Abstract][Full Text] [Related]
33. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
Bourgault AM; Lamothe F
J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324
[TBL] [Abstract][Full Text] [Related]
34. Comparison of oral immediate-release (IR) and extended-release (ER) metronidazole bactericidal activity against Bacteroides spp. using an in vitro model of infection.
Lewis RE; Klepser ME; Ernst EJ; Snabes MA; Jones RN
Diagn Microbiol Infect Dis; 2000 May; 37(1):51-5. PubMed ID: 10794941
[TBL] [Abstract][Full Text] [Related]
35. Comparative evaluation of the 2-methyl-5-nitroimidazole compounds dimetridazole, metronidazole, secnidazole, ornidazole, tinidazole, carnidazole, and panidazole against Bacteroides fragilis and other bacteria of the Bacteroides fragilis group.
Jokipii L; Jokipii AM
Antimicrob Agents Chemother; 1985 Oct; 28(4):561-4. PubMed ID: 4073879
[TBL] [Abstract][Full Text] [Related]
36. [Sensitivity of strict anaerobic bacteria to metronidazole, cefoxitin, and clindamycin].
Dubreuil L; Derriennic M; Reynaud A; Devos J; Romond C; Courtieu A
Pathol Biol (Paris); 1985 Nov; 33(9):899-903. PubMed ID: 3909082
[TBL] [Abstract][Full Text] [Related]
37. A reassessment of the activity of the third-generation cephalosporins against anaerobes and Staphylococcus aureus.
Canawati HN
Am J Surg; 1992 Oct; 164(4A Suppl):24S-27S. PubMed ID: 1443357
[TBL] [Abstract][Full Text] [Related]
38. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan.
Teng LJ; Hsueh PR; Tsai JC; Liaw SJ; Ho SW; Luh KT
Antimicrob Agents Chemother; 2002 Sep; 46(9):2908-13. PubMed ID: 12183246
[TBL] [Abstract][Full Text] [Related]
39. Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria.
Borobio MV; Perea EJ
Antimicrob Agents Chemother; 1984 Mar; 25(3):342-3. PubMed ID: 6721466
[TBL] [Abstract][Full Text] [Related]
40. In vitro synergy of ciprofloxacin and three other antibiotics against Bacteroides fragilis.
Esposito S; Gupta A; Thadepalli H
Drugs Exp Clin Res; 1987; 13(8):489-92. PubMed ID: 3428131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
